Dioscin inhibited the MAPK pathway, which has a significant role in the growth of cancer cells and metastasis, as well as inhibiting the EMT malignant transformation triggered by TGF‐β1 in HepG2 liver cancer cells.170. Here, TGFB1 is linked to liver cancer.